Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma

Non-muscle invasive bladder cancer (NMIBC) has traditionally been managed with transurethral resection followed by intravesical chemotherapy and/or bacillus Calmette–Guerin (BCG) in a risk-adapted manner. These tumors commonly recur and can progress potentially to lethal muscle invasive disease. A m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassaie, Omid, Chehroudi, Cyrus, Black, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366114/
https://www.ncbi.nlm.nih.gov/pubmed/34408797
http://dx.doi.org/10.1177/17588359211039052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366114/
https://www.ncbi.nlm.nih.gov/pubmed/34408797
http://dx.doi.org/10.1177/17588359211039052

Ejemplares similares